SD Biosensor (137310) Stock Price, Fundamentals & Analysis
Price
6,070 KRW
-0.66%
Last trade: Sep 23, 2026, 03:30 PM GMT+9
Updated: Sep 27, 2026, 06:30 PM GMT+9
Price history
Over the past year 137310 traded between 5,820 KRW and 10,080 KRW, closing at 6,070 KRW on Sep 23, 2026.
Key statistics
| Market cap | 726.09B KRW |
|---|---|
| Dividend yield | 3.29% |
| Annual dividend | 200 KRW |
| Ex-dividend date | Mar 30, 2026 |
| Payout ratio | 0% |
| 52-week range | 5,800 – 10,210 |
| 52-week change | -39.3% |
| Beta | 0.71 |
| Revenue (TTM) | 738.76B KRW |
| Revenue growth (YoY) | 12% |
| Gross margin | 46.2% |
| Operating margin | -2.9% |
| Profit margin | -98.7% |
| Return on equity | -26.9% |
| Debt / equity | 12 |
| Volume | 100,108 |
| Average volume | 153,474 |
| Exchange | KSE |
Profile
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 616
- Headquarters
- Suwon-si, South Korea
- Website
- sdbiosensor.com
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides STANDARD i, an analyzer based on chemiluminescence immunoassay technology for detection of clinical biomarkers, including hormones, tumor markers, and infectious diseases; blood glucose meter products; and other products, such as transport medium, d-BLOCK incubator, G6PD analyzer, LipidoCare analyzer, MultiCare analyzer, and Pilot COVID-19 at-home test. The company exports its products. SD Biosensor, Inc. was founded in 1999 and is headquartered in Suwon-si, South Korea.
Overview
What 137310 does
SD Biosensor (137310) is a stock listed on the Korea Exchange in the Healthcare sector, specifically the Medical Devices industry. The company designs and manufactures in-vitro diagnostic products, including rapid test kits, fluorescence immunoassay systems, and molecular diagnostic platforms for infectious diseases, drug resistance, and genetic testing. It also produces clinical biomarker analyzers, blood glucose meters, and other medical devices, exporting its products across Asia, Europe, the Americas, and Africa.
Key numbers explained
- Price of 6,070 KRW is the most recent trading price per share on the Korea Exchange.
- Market cap of 726.09 mld. KRW reflects the total market value of all outstanding shares.
- Dividend yield of 3.29% shows the annual dividend payment as a percentage of the current share price; the exDividendDate is Mar 30, 2026.
- Beta of 0.71 suggests the stock has historically been less volatile than the overall market.
- 52-week range of 5,800 – 10,210 KRW indicates the lowest and highest prices traded over the past year.
- Revenue growth of 12% year over year describes the increase in trailing 12-month sales.
- Debt-to-equity ratio of 12% measures financial leverage relative to shareholders' equity.
- Share of earnings paid out as dividends is 0%, meaning no portion of net income is currently distributed as dividends.
What to watch
Investors tracking Healthcare stocks like SD Biosensor often monitor regulatory approvals, product launches, and changes in diagnostic demand. The company's export exposure means it can be sensitive to currency movements and international trade conditions. As a smaller-cap stock, liquidity and trading volume may vary, which can affect execution for larger positions. Peer companies such as Hanmi Pharm (128940), Celltrion (068270), and Samsung Biologics (207940) operate in related segments of the Korean healthcare ecosystem.
Latest news & filings
No recent headlines.
Frequently asked questions
Does 137310 pay a dividend?
The dividend yield is listed as 3.29%, but the share of earnings paid out as dividends is 0%, so no current earnings are distributed.
What is the 137310 P/E ratio?
The P/E ratio is not provided in the available facts.
Where can I buy 137310?
It trades on the Korea Exchange under the symbol 137310.
What sector is SD Biosensor in?
It is in the Healthcare sector, within the Medical Devices industry.
How volatile is 137310 compared to the market?
Its beta of 0.71 suggests it has been less volatile than the broader market.
What is the 52-week price range for 137310?
The lowest and highest price in the last 52 weeks is 5,800 – 10,210 KRW.
Related
More on 137310
Track 137310 in your portfolio
Hold 137310 at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.
Start free